A BRIAN DAVIS
CIK 1184432 · Chief Financial Officer · last filed 2026-01-12
A BRIAN DAVIS is a Chief Financial Officer who has filed 20 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for GRCE, was dated Jan 12, 2026. Across all open-market trades the lifetime net is +$98.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $73.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$73.9K
6
20
$98.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GRCE | Director | — | $2.20 | — | $0 | 2 | 2026-01-12 |
| Grace Therapeutics, Inc. (ACST) Delisted | Director | — | $3.37 | — | $0 | 1 | 2023-12-20 |
| VRCA | Chief Financial Officer | 12,900 | $5.73 | $73.9K | $98.7K | 5 | 2021-06-07 |
| Strongbridge Biopharma plc (SBBP) Delisted | Chief Financial Officer | 33,366 | $2.00 | $66.7K | $0 | 3 | 2019-02-22 |
| TENGION INC (TNGN) Delisted | Chf. Fin. Offr, VP Fin. | 91,666 | — | — | $0 | 3 | 2012-02-21 |
| NEOSE TECHNOLOGIES INC (NTEC) Delisted | Sr. Vice President and CFO | 33,650 | $9.63 | $324.0K | $0 | 5 | 2008-02-05 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-12 | GRCE | Grant (A) | — | $0 | EDGAR |
| 2025-05-13 | GRCE | Grant (A) | — | $0 | EDGAR |
| 2023-12-20 | Grace Therapeutics, Inc. (ACST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-07 | VRCA | Buy (P) | +5,000 | $49.5K | EDGAR |
| 2021-03-03 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2020-08-17 | VRCA | Buy (P) | +7,900 | $49.3K | EDGAR |
| 2020-03-02 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2019-10-21 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2019-02-22 | Strongbridge Biopharma plc (SBBP) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2018-02-28 | Strongbridge Biopharma plc (SBBP) Delisted | Tax (F) | −8,696 | -$57.4K | EDGAR |